Active-ingredient Dossier
Fluticasone Furoate
Active-ingredient Dossier for Fluticasone Furoate (intranasal corticosteroid). Australian brands, products, PBS listings, PBAC outcomes — compiled by…
- Brand: ARNUITY ELLIPTA
- Brand: TRELEGY ELLIPTA
- Brand: BREO ELLIPTA
- Brand: AVAMYS
- Brand: ARX-FLUTICASONE
- Brand: FLUTICASONE
- Therapeutic area: Respiratory
What is
Fluticasone Furoate Fluticasone Furoate is an intranasal corticosteroid.
Australian brands containing
Fluticasone Furoate — ARNUITY ELLIPTA — TRELEGY ELLIPTA — BREO ELLIPTA — AVAMYS — ARX-FLUTICASONE — FLUTICASONE — FLUTICAMYS — FLUTICASONE-RKM — FLUTICASONE-WGR
Therapeutic areas
Fluticasone Furoate is registered in respiratory therapeutic area, with 10 brands containing this ingredient on the ARTG.
Sponsor landscape
Three sponsors market fluticasone furoate in Australia: Helix Pharmaceuticals, GlaxoSmithKline, and Boucher & Muir.
PBS and regulatory activity
One brand containing fluticasone furoate has PBS-listed items, with the latest PBS schedule date of 1 May 2026. The latest PBAC outcome was recorded on 1 November 2021, with four brands having PBAC outcomes on record. No brands have AusPARs on record.